Revvity

Revvity

Yahoo Finance • 6 days ago

Revvity Board Declares Quarterly Dividend

WALTHAM, Mass., October 30, 2026--(BUSINESS WIRE)--The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on February 12, 2027 to all s... Full story

Yahoo Finance • 8 days ago

2 S&P 500 stocks with competitive advantages and 1 we turn down

2 S&P 500 stocks with competitive advantages and 1 we turn down The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn't mean every stock is worth owning. Some companies face significant challenges, whether... Full story

Yahoo Finance • 20 days ago

1 Cash-Producing Stock to Own for Decades and 2 We Question

1 Cash-Producing Stock to Own for Decades and 2 We Question Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to... Full story

Yahoo Finance • 23 days ago

Revvity to Present at Upcoming Investor Conferences

WALTHAM, Mass., October 13, 2026--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences: 2026 Jefferies Global Healthcare Conference Tuesday, November 17, 2026 8:00 a.m. GMT –... Full story

Yahoo Finance • 29 days ago

Cell-Based Assay & High Content Screening Market Report Reveals Why Technology Is Outpacing the Market, Profiling Thermo Fisher, Roche, Sartorius, Revvity & 50 Other Key Players

Company Logo 281-Page Report Tracks Post-Pandemic Research Growth Across Pharma, Research and Industry/Cosmetic Users as 3D Assays, Automation and Immuno-oncology Reshape Drug Discovery Dublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- "Cell-Bas... Full story

Yahoo Finance • last month

Moderna, Illumina lead healthcare gains in September as medtech drags

[Close-Up Shot of Scientists Hands typing Data in Laptop in Laboratory] Tom Werner Healthcare stocks underperformed the broader market in September, with the Health Care Select Sector SPDR Fund (XLV [https://seekingalpha.com/symbol/XLV])... Full story

Yahoo Finance • last month

Top Midday Stories: Oracle's Data Center Delay; People Withdraws MGM Offer; Revvity's New Diabetes Test

All three major US stock indexes fell in late-morning trading Thursday amid uncertainty in the Middl PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

Capitalize on the Label-Free Detection Market Shift: Track How Danaher, Sartorius, Agilent, Bruker and Revvity Are Disrupting R&D ROI and Reshaping Global Revenue Through 2030

Company Logo AI-enabled, microfluidic label-free detection is expanding in drug discovery, early diagnostics, food safety and environmental testing, driven by efficient, non-invasive, sustainable workflows. Dublin, Sept. 22, 2026 (GLOBE... Full story

Yahoo Finance • last month

Capitalize on High Content Screening Disruption: Decode How Thermo Fisher Scientific, Danaher, Revvity, and Yokogawa Are Reshaping Global R&D ROI and Revenue

Company Logo High-content screening is advancing drug discovery and personalized medicine, driven by 3D models, advanced imaging and automated analytics, with opportunities in cancer research and organoids. Dublin, Sept. 22, 2026 (GLOBE... Full story

Yahoo Finance • 2 months ago

Notable healthcare headlines for the week: Novo Nordisk, GE HealthCare, and Eli Lilly in focus

Wall Street's major market averages finished mixed as Treasury yields rebounded, rekindling concerns about a deteriorating macroeconomic backdrop. The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-n... Full story

Yahoo Finance • 2 months ago

Revvity slips as CFRA downgrades on limited near-term upside

[Wall Street sign in Lower Manhattan, NYC] georgeclerk Revvity (RVTY [https://seekingalpha.com/symbol/RVTY]) shares fell on Friday following a five-day winning streak as CFRA downgraded the life sciences company to Hold from Buy, citing a... Full story

Yahoo Finance • 2 months ago

Stock futures rise as Fed rate decision takes center stage

[Wall Street street sign in Manhattan financial district] Alexey_Fedoren Stock index futures were higher on Wednesday as investors focused on the Federal Reserve's interest rate decision. Dow futures (INDU [https://seekingalpha.com/symbo... Full story

Yahoo Finance • 2 months ago

Stocks making the biggest moves midday: Skyworks Solutions, Axon, Dave & Buster's, Revvity & more

Check out the companies making the biggest moves midday: Skyworks Solutions , Qorvo — The chipmakers popped, recovering from a sell-off in the previous session driven by safety concerns around artificial trade. Skyworks traded 10% higher,... Full story

Yahoo Finance • 2 months ago

Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others

Company Logo 500-Page Report Spans 450 Data Tables Across Product, Species, Host Cell, and Application Segments as Human Recombinant Proteins Lead Demand Research Use Recombinant Protein MarketResearch Use Recombinant Protein Market Dub... Full story

Yahoo Finance • 2 months ago

Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks

[Health Care Medical Concept] ogichobanov/iStock via Getty Images The healthcare sector (XLV [https://seekingalpha.com/symbol/XLV]) gained 4.91% in August, outperforming the broader S&P 500 (SPY [https://seekingalpha.com/symbol/SPY]), whi... Full story

Yahoo Finance • 2 months ago

Is Revvity Stock a Buy as Growth Improves but Valuation Stays Rich?

Revvity, Inc. RVTY is entering the second half of 2026 with stronger operating momentum. Raised guidance, double-digit Diagnostics growth and better cash generation have improved the earnings setup. The counterweight is valuation. RVTY al... Full story

Yahoo Finance • 2 months ago

Revvity (RVTY) Stock Looks Fair On Cash Flow Yet Pricey On Earnings

Revvity has delivered a strong 57.5% return over the past year, while valuation checks send mixed signals. The Discounted Cash Flow (DCF) intrinsic value estimate suggests the stock is roughly in line with fair value, and market-based mult... Full story

Yahoo Finance • 3 months ago

Stock futures edge lower as traders focus on Strait of Hormuz reopening

[The New York Stock Exchange on the Wall street sign] Dmitry Vinogradov Stock index futures were lower on Tuesday as traders continued to focus on developments related to the reopening of the Strait of Hormuz. Dow futures (INDU [https://... Full story

Yahoo Finance • 3 months ago

1 Profitable Stock on Our Buy List and 2 We Find Risky

1 Profitable Stock on Our Buy List and 2 We Find Risky While profitability is essential, it doesn't guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, "... Full story

Yahoo Finance • 3 months ago

Revvity outlines 2026 organic growth of 4% to 5% and adjusted EPS of $5.30 to $5.40, driven by diagnostics momentum and AI-linked demand

Earnings Call Insights: Revvity (RVTY) Q2 2026 MANAGEMENT VIEW * "I'm pleased to report that Revvity delivered strong results in the second quarter with pro forma organic growth of 3%, resulting in total revenue being above the high en... Full story